Savaria Corporation (T:SIS)
Business Focus: Elevator & Conveying Equipment
| Sector: Industrials | Industry: Heavy Electrical Equipment |
| Company Contact | |
| Address: | 4350 Chomedey (A-13) W LAVAL QC H7R 6E9 |
| Tel: | 1-800-9315655 |
| Website: | https://www.savaria.com |
| IR: | See website |
| Key People | ||
| Marcel Bourassa Executive Chairman of the Board | Laureen Cushing Global Vice President - Human Resources | Sebastien Bourassa President, Chief Executive Officer, Director |
| Stephen Reitknecht Chief Financial Officer | Vince Sciamanna President - Garaventa Lift group North America | Les Teague Group President, Patient Care |
| Clare Brophy Executive Vice President, Commercial Europe | Peter Slack Executive Vice President, Operations (Handicare / Garaventa Europe) | David Temple Vice President - Finance, Europe (Accessibility Segment) | Alexandre Bourassa Vice President - Sales |
| Business Overview |
| Savaria Corporation is a Canada-based company engaged in the accessibility industry. The Company provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its segments include Accessibility and Patient Care. It designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings. It operates a sales network of dealers worldwide and direct sales offices in North America, Europe (United Kingdom, The Netherlands, Switzerland, Italy, Germany, Poland and Czech Republic), Australia and China. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Savaria Corp revenues increased 6% to C$837M. Net income increased 7% to C$37.8M. Revenues reflect Accessibility segment increase of 17% to C$653.4M, Patient Handling segment increase of 6% to C$183.6M, Europe segment increase of 55% to C$335.9M, United States segment increase of 15% to C$359.2M. Net income benefited from Business integration costs decrease of 66% to C$1.8M (expense). |
| Employees: | 2,450 as of Dec 31, 2023 |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $1,476M as of Dec 31, 2023 |
| Annual revenue (TTM): | $836.95M as of Dec 31, 2023 |
| EBITDA (TTM): | $128.11M as of Dec 31, 2023 |
| Net annual income (TTM): | $37.84M as of Dec 31, 2023 |
| Free cash flow (TTM): | $25.40M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $265.31M as of Dec 31, 2023 |
| Shares outstanding: | 70,949,393 as of Mar 13, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
